<DOC>
	<DOC>NCT00499629</DOC>
	<brief_summary>The primary purpose of the study is to evaluate the safety of FXR-450 in healthy subjects. This study will also evaluate pharmacokinetics (PK) of FXR-450 in healthy subjects.</brief_summary>
	<brief_title>Study Evaluating the Safety of FXR-450 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Men or women of nonchildbearing potential (WONCBP) aged 18 to 50 years inclusive at screening. Healthy as determined by the investigator on the basis of screening evaluations. Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Must be able to abstain from smoking during the inpatient stay. Any significant medical disease. History of cholecystectomy (removal of gallbladder). Any clinically important finding in physical examination, vital signs, 12lead electrocardiograms (ECGs), or clinical laboratory test results.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>healthy subjects</keyword>
</DOC>